|
Endovascular Treatment for Chronic
Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis (MS)
Patients
What Liberation Treatment is all about?
This is a whole
new approach for treating the patients with Multiple Sclerosis. In
recent days it has become a new hope for millions of Multiple
Sclerosis patients across the world. Dr. Paolo Zamboni, a former
vascular surgeon and professor at the University of Ferrara in
northern Italy developed this procedure while he was trying to
understand the underlying causes for the condition which his wife was
into a, Multiple Sclerosis (MS).
What is Multiple Sclerosis (MS)
First diagnosed
in the year 1849, Multiple sclerosis (MS) is a nervous system disease
that affects brain and the spinal cord. It is also known as
disseminated sclerosis or encephalomyelitis disseminata. The disease
affects an estimated 2.5 million people around the world, causing
physical and mental disabilities that can gradually destroy a
patient's quality of life. It damages the myelin sheath, the material
that surrounds and protects your nerve cells. This damage slows down
or blocks messages between your brain and your body, leading to the
symptoms of MS like visual disturbances, muscle weakness, trouble with
coordination and balance, sensations such as numbness, prickling,
thinking and memory problems etc. Multiple sclerosis affects women
more than men. It often begins between the ages of 20 and 40. Usually,
the disease is mild, but some people lose the ability to write, speak
or walk. MS is five times more prevalent in temperate climates-such as
those found in the northern United States, Canada, and Europe-than in
tropical regions.
What is CSSVI all about?
CCSVI
stands for
Chronic cerebrospinal venous insufficiency
is a chronic problem where blood from the brain and spine has trouble
getting back to the heart. It’s caused by stenosis (a narrowing) in
the veins that drain the spine and brain. Blood takes longer to get
back to the heart, and it can reflux back into the brain and spine or
cause edema and leakage of red blood cells and fluids into the
delicate tissue of the brain and spine. Blood that stays in the brain
for too long creates “slowed perfusion” and a delay in deoxygenated
blood leaving the head. This can cause a lack of oxygen (hypoxia) in
the brain.
1. Relation between CCSVI and MS; Dr. Zamboni’s
finding
It all started
with the Dr. Paolo Zamboni’s search to find out the root cause of
debilitating condition of his wife who was suffering with Multiple
Sclerosis. After studying many patients suffering from the same
condition, he found that that almost all of them had a abnormal
narrowing, twisting or outright blockage of the veins that are
supposed to flush blood from the brain. Further Dr. Paolo Zamboni
found that whichever patient had this condition, had a high level of
deposition of Iron in the veins. Lack of free flow of the blood to the
brain possibly explaining the symptoms of MS.
2. The Liberation Treatment or the
Liberation Procedure;- Dr.
Zamboni’s Invention
Now the idea was
to open up such blocks and allow the free flow of blood through veins
to brain. This is the reason why this procedure is called as
Liberation Procedure or Liberation Treatment. This is done in the
similar way as it is done in Coronary Balloon procedure. The patient
may have single blockage or multiple blockages. Accordingly the
treatment is decided.
How is this connected to Multiple Sclerosis?
It is believed
that due to CCVSI, iron builds up in the brain, blocking and damaging
crucial blood vessels. This causes the vessels to rupture, which
allows both the iron and immune cells from the bloodstream, to cross
the blood-brain barrier into the cerebro-spinal fluid. Once the immune
cells have direct access to the immune system, they begin to attack
the myelin sheathing of the cerebral nerves, and result in the
development of Multiple Sclerosis.
1.
Purpose and Background Information:
The Endovascular
procedure for Chronic Cerebro Spinal Venous Insufficiency (CCSVI) with
Multiple Sclerosis (MS) will be performed by Dr. Santosh Prabhu.
Please not that this procedure is not FDA approved treatment for
Multiple Sclerosis and is still being studied for its benefits in
patients of Multiple Sclerosis .
2. Procedure For CCSVI Related To Multiple Sclerosis:
In this
procedure, an angiographic catheter will be moved from the inferior to
the superior vena cava and the venous pressure is measured.
Catheterization will be proceeded to Azygous (AZY) vein for few
millimeters and then to the distal Internal jugular vein (IJV).
In this
procedure Compliant-type balloon catheters will be used because of
their greater flexibility allows for insertion in the narrow arch of
the AZY. Inflations are maintained as per requirement and will be
repeated several times.
At the end
of the therapeutic procedure, the post-procedure venous pressure
measurement and selective phlebograpy of the AZY or IJVs, or both, is
repeated to document the immediate outcome of the treatment.
The exact mode of intervention undertaken and the associated local
anesthesia procedure will be performed in keeping with your
physician’s standard treatment practices and your individual condition
at the time of examination and will be discussed in detail with you.
3. Eligibility Criteria For The Procedure:
Patients who are
eligible as per the following inclusion and exclusion criteria and who
wish to undergo this procedure will be asked to sign the consent form.
Inclusion
Criteria:
-
Age: 18 – 65
years; Gender: Male and Female
Expanded Disability Disease
Scale Score (EDSS) ranging from 0 to 6.5
-
Active
Diagnosis / Relapse of MS with CCSVI according to the revised Mc
Donald Criteria
-
Therapy with
currently Food and Drug Administration (FDA)-approved
disease-modifying treatments
-
Evidence of
more than two Echo Color Doppler parameters or MRV of suspicious
abnormal extracranial cerebral venous outflow
-
Normal renal
function
Exclusion
Criteria
-
Relapse and
disease progression related to MS other than CCSVI.
-
Treatment with
Steroids in the 30 days preceding the procedure
-
Pre-existing
medical condition known to be associated with brain pathology,
including neurodegenerative disorder, cerebro-vascular disease, and
history of alcohol abuse
-
Abnormal renal
function
-
Refusal to
undergo the endovascular treatment
|